The Discounted Cash Flow (DCF) valuation of Moberg Pharma AB (publ) (MOB.ST) is (6,483.27) SEK. With the latest stock price at 8.57 SEK, the upside of Moberg Pharma AB (publ) based on DCF is -75750.8%.
Based on the latest price of 8.57 SEK and our DCF valuation, Moberg Pharma AB (publ) (MOB.ST) is a sell. selling MOB.ST stocks now will result in a potential gain of 75750.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 4.9% - 6.5% | 5.7% |
| Long-term Growth Rate | 3.0% - 4.6% | 3.8% |
| Fair Price | (37,355.08) - (3,570.72) | (6,483.27) |
| Upside | -435981.9% - -41765.3% | -75750.8% |